Drugs of Abuse Testing Markets: Forecasts to 2018 (Lab-Based, Professional POC, Home, Employment, Criminal Justice Markets)

   Single User - $995
   Site License (one location, 10 users) - $1,495
   Corporate License - $1,990

Published Jul 14, 2014 | 150 Pages | Pub ID: KLI5295379

Drugs of Abuse is an important growth category in IVD testing with competitive participation by top IVD vendors for market share. Healthcare professionals, employers, criminal justice personnel, and sports use drug tests as part of a comprehensive evaluation of individuals to reach a correct decision regarding the individuals’ actions, behaviors or performances.  This report covers trends and markets in drugs of abuse testing. As part of its coverage, the report offers estimates and forecasts for drugs of abuse markets, and the following market segment estimates:

Market by Type of Sample (Urine, Oral, Blood, Hair)  

Market by Application, including: 
  • Employment
  • Criminal Justice 
  • Lab-based IVD
  • Professional POC
  • Home OTC

Market by Region (US, EUR, ROW)

Market Share by Provider 

The report’s geographic scope is worldwide with information for specific geographical regions; world demographics;, and other general issues affecting the market The market summary includes market analysis by product and region and a competitive analysis of leading providers. Additionally, key company profiles are included. The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals.

 Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 12 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

A group of diversified companies is involved in the development or marketing of drugs of abuse testing and technology products. The market is considered evolving with growth opportunity. Drug abuse is a worldwide problem and it is growing. Key companies such as Roche Diagnostics, Abbott Diagnostics and Siemens Healthcare will likely maintain leading positions in the market through continued product innovation and strategic alliances and mergers. Among the top and/or innovative competitors discussed within Corporate Profiles are:
  • 1st Step Detect Associates
  • Abbott Diagnostics
  • AccuTech
  • Alere
  • Alfa Scientific
  • Amedica Biotech
  • American Bio Medica
  • Atlas Link Biotech
  • Beckman Coulter
  • Biophor Diagnostics
  • Bio-Medical Products
  • Bio-Rad Laboratories
  • BioScan Screening Systems
  • Branan Medical Corp
  • Confirm Biosciences
  • DeVon Medical Products
  • IDenta Corp
  • Lifeloc Technologies
  • LifeSign
  • MAVAND Solutions
  • MedTest Dx
  • Mossman Associates
  • MP BioMedicals
  • Nano-Ditech Corp
  • OraSure
  • Ortho Clinical Diagnostics
  • Polymed Therapeutics
  • PreChek Bio
  • Princeton Biomedtech
  • Psychemedics
  • Randox Laboratories
  • Redwood Toxicology
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • UCP Biosciences
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.